• Thumbnail for Ribociclib
    Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor...
    16 KB (1,447 words) - 02:46, 31 March 2024
  • FDA approved, but several compounds are in clinical trials. See also Ribociclib#Mechanism of action re: CDK4 The cell cycle is a highly regulated process...
    24 KB (2,633 words) - 00:57, 22 April 2024
  • Thumbnail for Palbociclib
    approved ribociclib, owned by Novartis, as a combination therapy with aromatase inhibitors for indications similar to those of palbociclib and ribociclib. Notably...
    37 KB (3,559 words) - 05:40, 7 April 2024
  • Thumbnail for Abemaciclib
    shown in a study with rifampicin. Like the related drugs palbociclib and ribociclib, abemaciclib inhibits the enzymes cyclin-dependent kinase 4 (CDK4) and...
    17 KB (1,434 words) - 05:00, 24 March 2024
  • Thumbnail for Breast cancer
    fulvestrant, often used in combination with CDK4/6 inhibitors (palbociclib, ribociclib, or abemaciclib). When one endocrine therapy fails, most will benefit...
    133 KB (14,898 words) - 19:40, 5 May 2024
  • Thumbnail for Tretinoin
    inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)...
    31 KB (2,940 words) - 06:07, 28 February 2024
  • Thumbnail for Methotrexate
    inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)...
    34 KB (3,112 words) - 09:16, 21 April 2024
  • Thumbnail for Hydroxycarbamide
    inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)...
    19 KB (1,767 words) - 04:36, 20 March 2024
  • Thumbnail for Cytarabine
    inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)...
    19 KB (1,681 words) - 07:11, 15 March 2024
  • Thumbnail for Cancer immunotherapy
    inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)...
    90 KB (9,943 words) - 14:26, 10 May 2024